KELLY M. MCMASTERS, M.D., PH.D.

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

PROVECTUS BIOPHARMACEUTICALS, INC.

Filing Date Source Excerpt
2010-04-30 Kelly M. McMasters, M.D., Ph.D., has clinical expertise in treating skin cancer, including melanoma, and surgical oncology.
2011-05-02 Kelly M. McMasters, M.D., Ph.D., has clinical expertise in treating skin cancer, including melanoma, and surgical oncology.
2012-04-30 Kelly M. McMasters, M.D., Ph.D., has clinical expertise in treating skin cancer, including melanoma, and surgical oncology.
2013-04-30 Kelly M. McMasters, M.D., Ph.D., 52, has served as a member of our board of directors since June 9, 2008.
2014-04-30 Kelly M. McMasters, M.D., Ph.D., 53, has served as a member of our board of directors since June 9, 2008.
2015-04-30 Kelly M. McMasters, M.D., Ph.D., has clinical expertise in treating skin cancer, including melanoma, and surgical oncology.
2016-04-29 Kelly M. McMasters, M.D., Ph.D., 55, has served as a member of our board of directors since June 9, 2008. ... He holds an MD/PhD from the University of Medicine and Dentistry of New Jersey.

Data sourced from SEC filings. Last updated: 2025-07-01